Power of Story Send a Tweet        
- Advertisement -
General News

FDA Grants Guinea Pig Status To US Citizens

By       Message Evelyn Pringle       (Page 1 of 3 pages)     Permalink

Related Topic(s): , Add Tags  Add to My Group(s)

View Ratings | Rate It

opednews.com

Author 58
- Advertisement -
"It is outrageous that, for all intents and purposes, the FDA allowed a clinical trial to proceed, which makes every citizen in the United States a potential "guinea pig, " without providing a practical, informative warning to the public."

The statement of outrage above was included in a letter to acting FDA Commissioner, Dr von Eschenbach, from Senator Charles Grassley (R-Iowa) on February 24, 2006. Senator Grassley has been keeping a close eye on the performance of the FDA in recent years.

As a Senator representing the State of Iowa and Chairman of the Committee on Finance, which has jurisdiction over the Medicare and Medicaid programs, the Senator wrote, "I am responsible for oversight of matters that affect my constituents and the beneficiaries of these federal health care programs."

In the letter, he advised Dr von Eschenbach that he found a recent Wall Street Journal article titled, "Amid Alarm Bells, A Blood Substitute Keeps Pumping, " alarming.

- Advertisement -
According to Sen Grassley, the WSJ says the FDA is allowing Illinois-based Northfield Laboratories to test a blood substitute called PolyHeme, in a clinical trial without the consent of patients, who may be unconscious or otherwise incapable of providing informed consent, pursuant to a rarely used FDA regulation, which allows for waiver of the consent required in clinical trials, if some type of community outreach program is put into practice.

"I understand the value of a viable blood substitute," Senator Grassley told Dr von Eschenbach in the letter, "but I 'm really disturbed by what I 'm hearing about the FDA 's role here and I want to find out what 's going on. "

PolyHeme contains hemoglobin processed from expired blood donations and is designed to be given to trauma victims in place of blood or saline solution. The product is supposed to be used as a temporary measure when there is a large blood loss and no readily available blood supply, according to Northfield.

- Advertisement -
Under guidelines for emergency teams participating in the study, at trauma sites, they administer PolyHeme to half of the patients, and standard saline solution to the other half. At the emergency room, patients who get PolyHeme at the trauma site continue to receive PolyHeme.

The 1996 federal regulation in question allows trials of possible life-saving treatments without patient consent if participating facilities inform members of the community about the trial and gauge public sentiment.

"I am skeptical," Sen Grassley told the FDA, "that any participating medical centers managed to conduct effective, practical outreach to the community and to provide a meaningful, informative warning to the public about the PolyHeme Study."

"If you 're in a car accident, of course you want emergency doctors to save your life, " Sen Grassley said in a press release. "But no reasonable person would expect to be treated as an experimental subject without consent," he added.

The trial is currently being conducted in 18 states that include California, Colorado, Delaware, Georgia, Illinois, Indiana, Kansas, Kentucky, Michigan, Minnesota, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Utah, and Virginia

So if you travel in these states and suffer a traumatic injury or need emergency treatment at a participating trauma center, you could become an unknowing research subject without your consent.

- Advertisement -
That is, unless you happen to be wearing a lightblue wristband imprinted with the statement: "I decline the Northfield PolyHeme Study."

This silly provision has further angered the Senator. "The idea that the FDA would put the burden on the public to opt out of this mass experiment is outrageous," he said.

An unknown number of community meetings were reportedly held in participating states and anyone who took time to attend a meeting could opt out by wearing continuously for an undetermined period of time one of these light-blue wristbands.

Next Page  1  |  2  |  3

 

- Advertisement -

View Ratings | Rate It

opednews.com

Evelyn Pringle is a columnist for OpEd News and investigative journalist focused on exposing corruption in government and corporate America.

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon Share Author on Social Media   Go To Commenting

The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
- Advertisement -

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Glaxo Promotes Mental Disorders - Then Paxil

Government Investigation Finds Autism Vaccine Related

Paxil Five-Year Litigation History

Suicide Risk of Neurontin Kept Hidden for Years

Gambro Healthcare - Dialysis Fraud Pays Big Bucks

Johnson & Johnson Chirate Spinal Disc Under Fire